Product Information
IBUPROFEN 100 MG/5 ML SUSP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0239 per ML under NDC 51672140909. Its NADAC has been published 134 times since Aug 2, 2023.
FDA first approved this application on Jun 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/5mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672140909
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA209204FDA Approved
6/23/2017
TE Code
AB
On Market Since
6/23/2017
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 100 MG/5 ML SUSP has been published 134 times since Aug 2, 2023, and over the history we have for it it has declined 16.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0239 per ML |
|---|---|
| All-time high | $0.0288 (Aug 16, 2023) |
| All-time low | $0.0185 (Nov 20, 2024) |
| 52-week high | $0.0256 |
| 52-week low | $0.0239 |
| Median price | $0.0254 |
| Average price | $0.0250 |
| Largest weekly change | +29.7% (Aug 21, 2024) |
| Weeks tracked | 134 |
| Tracking since | Aug 2, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-5.0%
3Y
-16.7%
5Y
N/A
All
-16.9%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IBUPROFEN 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 100 MG/5 ML SUSP, manufactured by Sun Pharmaceutical Industries Inc., is $0.0239 per ML (NDC 51672140909), effective Feb 18, 2026.
How has the price of IBUPROFEN 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has declined 16.9%. It has been tracked across 134 weekly CMS publications since Aug 2, 2023.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 100 MG/5 ML SUSP?
Since Aug 2, 2023, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has ranged from a low of $0.0185 (Nov 20, 2024) to a high of $0.0288 (Aug 16, 2023), with a median of $0.0254 per ML.
Are there cheaper alternatives to IBUPROFEN 100 MG/5 ML SUSP?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILDREN IBUPROFEN 100 MG/5 ML, is $0.0237 per ML — about 1% below IBUPROFEN 100 MG/5 ML SUSP.
Who manufactures IBUPROFEN 100 MG/5 ML SUSP?
IBUPROFEN 100 MG/5 ML SUSP (NDC 51672140909) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.